BioInsights - Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools

Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools

Cell & Gene Therapy Insights 2020; 6(8), 1047–1056

10.18609/cgti.2020.116

Published: 3 September 2020
Expert Insight
Apoorva Katragadda, Iftekhar Karimi, Xiaonan Wang

Graphical abstract